The cluster analysis heat map showed that the phase I-II and phase III-IV of elderly NSCLC patients were clearly separated, suggesting that the serum tumor markers CEA, CYFRA21-1, SCCA, CA125 and CA199 can distinguish the clinical stages of elderly NSCLC patients (Figure 2C). This evidence concerns the gene SERPINB3 and non-small cell lung carcinoma.